Skip to main content
SpringerLink
Log in

Interleukin-11, an IL-6-like cytokine

  • Cytokines
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

The aim of this review is to collect various data on different functions of interleukin-11 (IL-11), a member of a family of IL-6-like cytokines. Numerous in vitro experiments have suggested a long list of IL-11 properties including support and control of proliferation and differentiation of hematopoietic progenitors, as well as participation in osteoclastogenensis, neurogenesis, and development of some other tissues. However, a great number of in vitro effects of IL-11 have not been confirmed in experiments using murine models, hampering an understanding of the physiological role of this cytokine. We discuss possible reasons for the divergence between in vitro and in vivo data as well as the perspectives of using conditional gene targeting to assess the role of IL-11 in ontogenesis and immune response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J.F., Phillips J.H., McClanahan T.K., de Waal Malefyt R., Kastelein R.A. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225–2231.

    PubMed  CAS  Google Scholar 

  2. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M., Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K., Gorman D.M., Bazan J.F., de Waal Malefyt R., Rennick D., Kastelein R.A. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 16, 779–790.

    Article  PubMed  CAS  Google Scholar 

  3. Somers W., Stahl M., Seehra J.S. 1997. 1.9 of interleukin 6: Implications for a novel mode of receptor dimerization and signaling. EMBO J. 16, 989–997.

    Article  PubMed  CAS  Google Scholar 

  4. McDonald N.Q., Panayotatos N., Hendrickson W.A. 1995. Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. EMBO J. 14, 2689–2699.

    PubMed  CAS  Google Scholar 

  5. Robinson R.C., Grey L.M., Staunton D., Vankelecom H., Vernallis A.B., Moreau J.F., Stuart D.I., Heath J.K., Jones E.Y. 1994. The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding. Cell. 77, 1101–1116.

    Article  PubMed  CAS  Google Scholar 

  6. Hirano T., Nakajima K., Hibi M. 1997. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8, 241–252.

    Article  PubMed  CAS  Google Scholar 

  7. Diveu C., Lelievre E., Perret D., Lak-Hal A.H., Froger J., Guillet C., Chevalier S., Rousseau F., Wesa A., Preisser L., Chabbert M., Gauchat J.F., Galy A., Gascan H., Morel A. 2003. GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor. J. Biol. Chem. 278, 49850–49859.

    Article  PubMed  CAS  Google Scholar 

  8. Bazan J.F. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U.S.A. 87, 6934–6938.

    Article  PubMed  CAS  Google Scholar 

  9. Horsten U., Muller-Newen G., Gerhartz C., Wollmer A., Wijdenes J., Heinrich P.C., Grotzinger J. 1997. Molecular modeling-guided mutagenesis of the extra-cellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J. Biol. Chem. 272, 23748–23757.

    Article  PubMed  CAS  Google Scholar 

  10. Socolovsky M., Fallon A.E., Wang S., Brugnara C., Lodish H.F. 1999. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-X(L) induction. Cell. 98, 181–191.

    Article  PubMed  CAS  Google Scholar 

  11. Matadeen R., Hon W.C., Heath J.K., Jones E.Y., Fuller S. 2007. The dynamics of signal triggering in a gp130-receptor complex. Structure. 15, 441–448.

    Article  PubMed  CAS  Google Scholar 

  12. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. 1993. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 260, 1808–1810.

    Article  PubMed  CAS  Google Scholar 

  13. Skiniotis G., Lupardus P.J., Martick M., Walz T., Garcia K.C. 2008. Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex. Mol. Cell. 31, 737–748.

    Article  PubMed  CAS  Google Scholar 

  14. Lutticken C., Wegenka U.M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A.G., Wilks A.F., Yasukawa K., Taga T., Kishimoto T., Barbieri G., Pellegrini S., Sendtner M., Heinrich P.C., Horn F. 1994. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science. 263, 89–92.

    Article  PubMed  CAS  Google Scholar 

  15. Stahl N., Boulton T.G., Farruggella T., Ip N.Y., Davis S., Witthuhn B.A., Quelle F.W., Silvennoinen O., Barbieri G., Pellegrini S., Ihle J.N., Yancopoulos G.D. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science. 263, 92–95.

    Article  PubMed  CAS  Google Scholar 

  16. Stahl N., Farruggella T.J., Boulton T.G., Zhong Z., Darnell J.E., Jr., Yancopoulos G.D. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science. 267, 1349–1353.

    Article  PubMed  CAS  Google Scholar 

  17. Gerhartz C., Heesel B., Sasse J., Hemmann U., Landgraf C., Schneider-Mergener J., Horn F., Heinrich P.C., Graeve L. 1996. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130: I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. J. Biol. Chem. 271, 12991–12998.

    Article  PubMed  CAS  Google Scholar 

  18. Schaper F., Gendo C., Eck M., Schmitz J., Grimm C., Anhuf D., Kerr I.M., Heinrich P. C. 1998. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Biochem. J. 335(3), 557–565.

    PubMed  CAS  Google Scholar 

  19. Anderson K.C., Morimoto C., Paul S.R., Chauhan D., Williams D., Cochran M., Barut B.A. 1992. Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. Blood. 80, 2797–2804.

    PubMed  CAS  Google Scholar 

  20. Ariyama Y., Misawa S., Sonoda Y. 1995. Synergistic effects of stem cell factor and interleukin 6 or interleukin 11 on the expansion of murine hematopoietic progenitors in liquid suspension culture. Stem Cells. 13, 404–413.

    Article  PubMed  CAS  Google Scholar 

  21. Burstein S.A., Mei R.L., Henthorn J., Friese P., Turner K. 1992. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J. Cell. Physiol. 153, 305–312.

    Article  PubMed  CAS  Google Scholar 

  22. Peterson R.L., Bozza M.M., Dorner A.J. 1996. Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am. J. Pathol. 149, 895–902.

    PubMed  CAS  Google Scholar 

  23. Girasole G., Passeri G., Jilka R.L., Manolagas S.C. 1994. Interleukin-11: A new cytokine critical for osteoclast development. J. Clin. Invest. 93, 1516–1524.

    Article  PubMed  CAS  Google Scholar 

  24. Fann M.J., Patterson P.H. 1994. Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc. Natl. Acad. Sci. U.S.A. 91, 43–47.

    Article  PubMed  CAS  Google Scholar 

  25. Garcia Palacios V., Morita I., Murota S. 2001. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2. Prostagl. Leukot. Essent. Fatty Acids. 65, 215–221.

    Article  CAS  Google Scholar 

  26. Paul S.R., Yang Y.C., Donahue R.E., Goldring S., Williams D.A. 1991. Stromal cell-associated hematopoiesis: Immortalization and characterization of a primate bone marrow-derived stromal cell line. Blood. 77, 1723–1733.

    PubMed  CAS  Google Scholar 

  27. White C.A., Robb L., Salamonsen L.A. 2004. Uterine extracellular matrix components are altered during defective decidualization in interleukin-11 receptor alpha deficient mice. Reprod. Biol. Endocrinol. 2, 76.

    Article  PubMed  CAS  Google Scholar 

  28. Hermann J.A., Hall M.A., Maini R.N., Feldmann M., Brennan F.M. 1998. Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum. 41, 1388–1397.

    Article  PubMed  CAS  Google Scholar 

  29. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Kohler G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368, 339–342.

    Article  PubMed  CAS  Google Scholar 

  30. Dimitriadis E., Robb L., Liu Y.X., Enders A.C., Martin H., Stoikos C., Wallace E., Salamonsen L.A. 2003. IL-11 and IL-11Ralpha immunolocalisation at primate implantation sites supports a role for IL-11 in placentation and fetal development. Reprod. Biol. Endocrinol. 1, 34.

    Article  PubMed  CAS  Google Scholar 

  31. Cheng J.G., Chen J.R., Hernandez L., Alvord W.G., Stewart C.L. 2001. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc. Natl. Acad. Sci. U.S.A. 98, 8680–8685.

    Article  PubMed  CAS  Google Scholar 

  32. Curti A., Tafuri A., Ricciardi M.R., Tazzari P., Petrucci M.T., Fogli M., Ratta M., Lapalombella R., Ferri E., Tura S., Baccarani M., Lemoli R.M. 2002. Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1). Haematologica. 87, 373–380.

    PubMed  CAS  Google Scholar 

  33. Du X.X., Shi W.K. 1996. Study on growth and differentiation of ES cells transfected with LIF gene. Shi Yan Sheng Wu Xue Bao. 29, 413–427.

    PubMed  CAS  Google Scholar 

  34. Li W., Fishman M.C., Yuan J. 1996. Prevention of apoptosis in CNTF-dependent neurons by a mutant ICE and by viral protein CrmA but not by proto-oncogene product Bcl-2. Cell Death Differ. 3, 105–112.

    PubMed  CAS  Google Scholar 

  35. Silverman M.N., Miller A.H., Biron C.A., Pearce B.D. 2004. Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. Endocrinology. 145, 3580–3589.

    Article  PubMed  CAS  Google Scholar 

  36. Heinrich P.C., Behrmann I., Muller-Newen G., Schaper F., Graeve L. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334(2), 297–314.

    PubMed  CAS  Google Scholar 

  37. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W.Z., Mori C., Shiota K., Yoshida N., Kishimoto T. 1996. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. U.S.A. 93, 407–411.

    Article  PubMed  CAS  Google Scholar 

  38. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 94, 3801–3804.

    Article  PubMed  CAS  Google Scholar 

  39. Rodig S.J., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., King K.L., Sheehan K.C., Yin L., Pennica D., Johnson E.M., Jr., Schreiber R.D. 1998. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 93, 373–383.

    Article  PubMed  CAS  Google Scholar 

  40. McFarland-Mancini M.M., Funk H.M., Paluch A.M., Zhou M., Giridhar P.V., Mercer C.A., Kozma S.C., Drew A.F. 2010. Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J. Immunol. 184, 7219–7228.

    Article  PubMed  CAS  Google Scholar 

  41. Mysliwiec J., Zbucki R., Winnicka M.M., Sawicki B., Nikolajuk A., Kaminski K., Mysliwiec P., Musial W., Bondyra Z., Walecki J., Gorska M. 2007. A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosisrelated disturbances of bone turnover in mice. Horm. Metab. Res. 39, 884–888.

    Article  PubMed  CAS  Google Scholar 

  42. de Hooge A.S., van de Loo F.A., Bennink M.B., Arntz O.J., de Hooge P., van den Berg W.B. 2005. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging. Osteoarthr. Cart. 13, 66–73.

    Article  Google Scholar 

  43. Nandurkar H.H., Robb L., Tarlinton D., Barnett L., Kontgen F., Begley C.G. 1997. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. Blood. 90, 2148–2159.

    PubMed  CAS  Google Scholar 

  44. Francis N.J., Asmus S.E., Landis S. C. 1997. CNTF and LIF are not required for the target-directed acquisition of cholinergic and peptidergic properties by sympathetic neurons in vivo. Dev. Biol. 182, 76–87.

    Article  PubMed  CAS  Google Scholar 

  45. DeChiara T.M., Vejsada R., Poueymirou W.T., Acheson A., Suri C., Conover J.C., Friedman B., McClain J., Pan L., Stahl N., Ip N.Y., Yancopoulos G.D. 1995. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell. 83, 313–322.

    Article  PubMed  CAS  Google Scholar 

  46. Cafferty W.B., Gardiner N.J., Gavazzi I., Powell J., McMahon S.B., Heath J.K., Munson J., Cohen J., Thompson S.W. 2001. Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J. Neurosci. 21, 7161–7170.

    PubMed  CAS  Google Scholar 

  47. Li M., Sendtner M., Smith A. 1995. Essential function of LIF receptor in motor neurons. Nature. 378, 724–727.

    Article  PubMed  CAS  Google Scholar 

  48. Takahashi Y., Carpino N., Cross J.C., Torres M., Parganas E., Ihle J.N. 2003. SOCS3: An essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J. 22, 372–384.

    Article  PubMed  CAS  Google Scholar 

  49. Ware C.B., Horowitz M.C., Renshaw B.R., Hunt J.S., Liggitt D., Koblar S.A., Gliniak B.C., McKenna H.J., Papayannopoulou T., Thoma B., Cheng L., Donovan P.J., Peschon J.J., Bartlett P.F., Willis C.R., Wright B.D., Carpenter M.K., Davison B.L., Gearing D.P. 1995. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development. 121, 1283–1299.

    PubMed  CAS  Google Scholar 

  50. Esashi E., Ito H., Minehata K., Saito S., Morikawa Y., Miyajima A. 2009. Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis. Eur. J. Immunol. 39, 1664–1670.

    Article  PubMed  CAS  Google Scholar 

  51. Oberle S., Schober A., Meyer V., Holtmann B., Henderson C., Sendtner M., Unsicker K. 2006. Loss of leukemia inhibitory factor receptor beta or cardiotrophin-1 causes similar deficits in preganglionic sympathetic neurons and adrenal medulla. J. Neurosci. 26, 1823–1832.

    Article  PubMed  CAS  Google Scholar 

  52. Walker E.C., McGregor N.E., Poulton I.J., Pompolo S., Allan E.H., Quinn J.M., Gillespie M.T., Martin T.J., Sims N.A. 2008. Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J. Bone Miner. Res. 23, 2025–2032.

    Article  PubMed  CAS  Google Scholar 

  53. Diveu C., McGeachy M.J., Boniface K., Stumhofer J.S., Sathe M., Joyce-Shaikh B., Chen Y., Tato C.M., McClanahan T.K., de Waal Malefyt R., Hunter C.A., Cua D.J., Kastelein R.A. 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182, 5748–5756.

    Article  PubMed  CAS  Google Scholar 

  54. Shimanoe Y., Miyazaki Y., Hara H., Inokuchi A., Yoshida H. 2009. Amelioration of experimental allergic rhinitis with suppression of topical immune responses by lack of IL-27/WSX-1 signaling. Ann. Allergy Asthma Immunol. 102, 223–232.

    Article  PubMed  CAS  Google Scholar 

  55. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., Xia M., Wakeham A.C., Nishina H., Potter J., Saris C.J., Mak T.W. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity. 15, 569–578.

    Article  PubMed  CAS  Google Scholar 

  56. Perrigoue J.G., Li J., Zaph C., Goldschmidt M., Scott P., de Sauvage F.J., Pearce E.J., Ghilardi N., Artis D. 2007. IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J. Exp. Med. 204, 481–487.

    Article  PubMed  CAS  Google Scholar 

  57. Perrigoue J.G., Zaph C., Guild K., Du Y., Artis D. 2009. IL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infection. J. Immunol. 182, 6088–6094.

    Article  PubMed  CAS  Google Scholar 

  58. Broxmeyer H.E., Li J., Hangoc G., Cooper S., Tao W., Mantel C., Graham-Evans B., Ghilardi N., de Sauvage F.J. 2007. Regulation of myeloid progenitor cell proliferation/survival by IL-31 receptor and IL-31. Exp. Hematol. 35, 78–86.

    Article  PubMed  CAS  Google Scholar 

  59. Paul S.R., Bennett F., Calvetti J.A., Kelleher K., Wood C.R., O’Hara R.M., Jr., Leary A.C., Sibley B., Clark S.C., Williams D.A., Yang Y.-C. 1990. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. U.S.A. 87, 7512–7516.

    Google Scholar 

  60. Morris J.C., Neben S., Bennett F., Finnerty H., Long A., Beier D.R., Kovacic S., McCoy J.M., DiBlasio-Smith E., La Vallie E.R., Caruso A., Calvetti J., Morris G., Weich N., Paul S.R., Crosier P.S., Turner K.J., Wood C.R. 1996. Molecular cloning and characterization of murine interleukin-11. Exp. Hematol. 24, 1369–1376.

    PubMed  CAS  Google Scholar 

  61. Czupryn M., Bennett F., Dube J., Grant K., Scoble H., Sookdeo H., McCoy J.M. 1995. Alanine-scanning mutagenesis of human interleukin-11: identification of regions important for biological activity. Ann. N.Y. Acad. Sci. 762, 152–164.

    Article  PubMed  CAS  Google Scholar 

  62. Czupryn M.J., McCoy J.M., Scoble H.A. 1995. Structure-function relationships in human interleukin-11: Identification of regions involved in activity by chemical modification and site-directed mutagenesis. J. Biol. Chem. 270, 978–985.

    Article  PubMed  CAS  Google Scholar 

  63. Murphy G.M., Jr., Bitting L., Majewska A., Schmidt K., Song Y., Wood C.R. 1995. Expression of interleukin-11 and its encoding mRNA by glioblastoma cells. Neurosci. Lett. 196, 153–156.

    Article  PubMed  CAS  Google Scholar 

  64. Elias J.A., Zheng T., Whiting N.L., Trow T.K., Merrill W.W., Zitnik R., Ray P., Alderman E.M. 1994. IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. J. Immunol. 152, 2421–2429.

    PubMed  CAS  Google Scholar 

  65. Elias J.A., Zheng T., Einarsson O., Landry M., Trow T., Rebert N., Panuska J. 1994. Epithelial interleukin-11: Regulation by cytokines, respiratory syncytial virus, and retinoic acid. J. Biol. Chem. 269, 22261–22268.

    PubMed  CAS  Google Scholar 

  66. Zheng T., Nathanson M.H., Elias J.A. 1994. Histamine augments cytokine-stimulated IL-11 production by human lung fibroblasts. J. Immunol. 153, 4742–4752.

    PubMed  CAS  Google Scholar 

  67. Du X.X., Williams D.A. 1994. Interleukin-11: A multifunctional growth factor derived from the hematopoietic microenvironment. Blood. 83, 2023–2030.

    PubMed  CAS  Google Scholar 

  68. Elias J.A., Tang W., Horowitz M. C. 1995. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology. 136, 489–498.

    Article  PubMed  CAS  Google Scholar 

  69. Romas E., Udagawa N., Zhou H., Tamura T., Saito M., Taga T., Hilton D.J., Suda T., Ng K.W., Martin T.J. 1996. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J. Exp. Med. 183, 2581–2591.

    Article  PubMed  CAS  Google Scholar 

  70. Maier R., Ganu V., Lotz M. 1993. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J. Biol. Chem. 268, 21527–21532.

    PubMed  CAS  Google Scholar 

  71. Du X.X., Scott D., Yang Z.X., Cooper R., Xiao X.L., Williams D.A. 1995. Interleukin-11 stimulates multi-lineage progenitors, but not stem cells, in murine and human long-term marrow cultures. Blood. 86, 128–134.

    PubMed  CAS  Google Scholar 

  72. Rier S.E., Parsons A.K., Becker J.L. 1994. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil. Steril. 61, 294–299.

    PubMed  CAS  Google Scholar 

  73. Paglia D., Oran A., Lu C., Kerbel R.S., Sauder D.N., McKenzie R. C. 1995. Expression of leukemia inhibitory factor and interleukin-11 by human melanoma cell lines: LIF, IL-6, and IL-11 are not coregulated. J. Interferon Cytokine Res. 15, 455–460.

    Article  PubMed  CAS  Google Scholar 

  74. Yang Y.C., Yin T. 1992. Interleukin-11 and its receptor. Biofactors. 4, 15–21.

    PubMed  CAS  Google Scholar 

  75. Wang X.Y., Fuhrer D.K., Marshall M.S., Yang Y. C. 1995. Interleukin-11 induces complex formation of Grb2, Fyn, and JAK2 in 3T3L1 cells. J. Biol. Chem. 270, 27999–28002.

    Article  PubMed  CAS  Google Scholar 

  76. Yin T., Yang Y. C. 1994. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J. Biol. Chem. 269, 3731–3738.

    PubMed  CAS  Google Scholar 

  77. Dahmen H., Horsten U., Kuster A., Jacques Y., Minvielle S., Kerr I.M., Ciliberto G., Paonessa G., Heinrich P.C., Muller-Newen G. 1998. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem. J. 331, 695–702.

    PubMed  CAS  Google Scholar 

  78. Leary A.G., Zeng H.Q., Clark S.C., Ogawa M. 1992. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc. Natl. Acad. Sci. U.S.A. 89, 4013–4017.

    Article  PubMed  CAS  Google Scholar 

  79. Jacobsen F.W., Keller J.R., Ruscetti F.W., Veiby O.P., Jacobsen S.E. 1995. Direct synergistic effects of IL-4 and IL-11 on proliferation of primitive hematopoietic progenitor cells. Exp. Hematol. 23, 990–995.

    PubMed  CAS  Google Scholar 

  80. Ploemacher R.E., van Soest P.L., Boudewijn A., Neben S. 1993. Interleukin-12 enhances interleukin-3 dependent multilineage hematopoietic colony formation stimulated by interleukin-11 or steel factor. Leukemia. 7, 1374–1380.

    PubMed  CAS  Google Scholar 

  81. Jacobsen S.E., Okkenhaug C., Veiby O.P., Caput D., Ferrara P., Minty A. 1994. Interleukin 13: Novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J. Exp. Med. 180, 75–82.

    Article  PubMed  CAS  Google Scholar 

  82. Musashi M., Yang Y.C., Paul S.R., Clark S.C., Sudo T., Ogawa M. 1991. Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture. Proc. Natl. Acad. Sci. U.S.A. 88, 765–769.

    Article  PubMed  CAS  Google Scholar 

  83. Schibler K.R., Yang Y.C., Christensen R.D. 1992. Effect of interleukin-11 on cycling status and clonogenic maturation of fetal and adult hematopoietic progenitors. Blood. 80, 900–903.

    PubMed  CAS  Google Scholar 

  84. Bruno E., Briddell R.A., Cooper R.J., Hoffman R. 1991. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp. Hematol. 19, 378–381.

    PubMed  CAS  Google Scholar 

  85. Broudy V.C., Lin N.L., Kaushansky K. 1995. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood. 85, 1719–1726.

    PubMed  CAS  Google Scholar 

  86. Yonemura Y., Kawakita M., Masuda T., Fujimoto K., Kato K., Takatsuki K. 1992. Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. Exp. Hematol. 20, 1011–1016.

    PubMed  CAS  Google Scholar 

  87. Kaushansky K., Broudy V.C., Lin N., Jorgensen M.J., McCarty J., Fox N., Zucker-Franklin D., Lofton-Day C. 1995. Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc. Natl. Acad. Sci. U.S.A. 92, 3234–3238.

    Article  PubMed  CAS  Google Scholar 

  88. Neben T.Y., Loebelenz J., Hayes L., McCarthy K., Stoudemire J., Schaub R., Goldman S.J. 1993. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood. 81, 901–908.

    PubMed  CAS  Google Scholar 

  89. Carver-Moore K., Broxmeyer H.E., Luoh S.M., Cooper S., Peng J., Burstein S.A., Moore M.W., de Sauvage F.J. 1996. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood. 88, 803–808.

    PubMed  CAS  Google Scholar 

  90. Jenkins B.J., Roberts A.W., Greenhill C.J., Najdovska M., Lundgren-May T., Robb L., Grail D., Ernst M. 2007. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Blood. 109, 2380–2388.

    Article  PubMed  CAS  Google Scholar 

  91. Podkolodnaia O.A., Stepanenko I.L. 1997. Mechanisms of transcriptional regulation of erythroid specific genes. Mol. Biol. (Moscow). 31, 562–574.

    Google Scholar 

  92. Hassan H.T., Biermann B., Zander A.R. 1996. Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11. Eur. Cytokine Netw. 7, 129–136.

    PubMed  CAS  Google Scholar 

  93. Quesniaux V.F., Clark S.C., Turner K., Fagg B. 1992. Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. Blood. 80, 1218–1223.

    PubMed  CAS  Google Scholar 

  94. Rodriguez M.H., Arnaud S., Blanchet J. P. 1995. IL-11 directly stimulates murine and human erythroid burst formation in semisolid cultures. Exp. Hematol. 23, 545–550.

    PubMed  CAS  Google Scholar 

  95. de Haan G., Dontje B., Engel C., Loeffler M., Nijhof W. 1995. In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis. Br. J. Haematol. 90, 783–790.

    Article  PubMed  Google Scholar 

  96. Tsuji K., Lyman S.D., Sudo T., Clark S.C., Ogawa M. 1992. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood. 79, 2855–2860.

    PubMed  CAS  Google Scholar 

  97. Ku H., Yonemura Y., Kaushansky K., Ogawa M. 1996. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood. 87, 4544–4551.

    PubMed  CAS  Google Scholar 

  98. Hawley R.G., Fong A.Z., Ngan B.Y., de Lanux V.M., Clark S.C., Hawley T.S. 1993. Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras. J. Exp. Med. 178, 1175–1188.

    Article  PubMed  CAS  Google Scholar 

  99. Hirayama F., Shih J.P., Awgulewitsch A., Warr G.W., Clark S.C., Ogawa M. 1992. Clonal proliferation of murine lymphohemopoietic progenitors in culture. Proc. Natl. Acad. Sci. U.S.A. 89, 5907–5911.

    Article  PubMed  CAS  Google Scholar 

  100. Yin T.G., Schendel P., Yang Y.C. 1992. Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11. J. Exp. Med. 175, 211–216.

    Article  PubMed  CAS  Google Scholar 

  101. Mehler M.F., Rozental R., Dougherty M., Spray D.C., Kessler J.A. 1993. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature. 362, 62–65.

    Article  PubMed  CAS  Google Scholar 

  102. Honma K., Koles N.L., Alam H.B., Keith J.C., Jr., Pollack M. 2007. Dose-dependent effects of recombinant human interleukin-11 on the systemic hemodynamic function and urination. Kurume Med. J. 54, 73–76.

    Article  PubMed  CAS  Google Scholar 

  103. Lyadova I.V., Tsiganov E.N., Kapina M.A., Shepelkova G.S., Sosunov V.V., Radaeva T.V., Majorov K.B., Shmitova N.S., van den Ham H.J., Ganusov V.V., De Boer R.J., Racine R., Winslow G.M. 2010. In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of gr-1 cells in the lungs. PLoS One. 5, e10469.

    Article  PubMed  CAS  Google Scholar 

  104. Gurfein B.T., Zhang Y., Lopez C.B., Argaw A.T., Zameer A., Moran T.M., John G.R. 2009. IL-11 regulates autoimmune demyelination. J. Immunol. 183, 4229–4240.

    Article  PubMed  CAS  Google Scholar 

  105. Takeuchi Y., Watanabe S., Ishii G., Takeda S., Nakayama K., Fukumoto S., Kaneta Y., Inoue D., Matsumoto T., Harigaya K., Fujita T. 2002. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J. Biol. Chem. 277, 49011–49018.

    Article  PubMed  CAS  Google Scholar 

  106. Rajgopal R., Butcher M., Weitz J.I., Shaughnessy S.G. 2006. Heparin synergistically enhances interleukin-11 signaling through up-regulation of the MAPK pathway. J. Biol. Chem. 281, 20780–20787.

    Article  PubMed  CAS  Google Scholar 

  107. Lewis V.O., Ozawa M.G., Deavers M.T., Wang G., Shintani T., Arap W., Pasqualini R. 2009. The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res. 69, 1995–1999.

    Article  PubMed  CAS  Google Scholar 

  108. Yamazumi K., Nakayama T., Kusaba T., Wen C.Y., Yoshizaki A., Yakata Y., Nagayasu T., Sekine I. 2006. Expression of interleukin-11 and interleukin-11 receptor alpha in human colorectal adenocarcinoma: Immunohistochemical analyses and correlation with clinicopathological factors. World J. Gastroenterol. 12, 317–321.

    PubMed  CAS  Google Scholar 

  109. Menkhorst E., Salamonsen L., Robb L., Dimitriadis E. 2009. IL11 antagonist inhibits uterine stromal differentiation, causing pregnancy failure in mice. Biol. Reprod. 80, 920–927.

    Article  PubMed  CAS  Google Scholar 

  110. Ain R., Trinh M.L., Soares M.J. 2004. Interleukin-11 signaling is required for the differentiation of natural killer cells at the maternal-fetal interface. Dev. Dynam. 231, 700–708.

    Article  CAS  Google Scholar 

  111. Cantor S.B., Elting L.S., Hudson D.V., Jr., Rubenstein E.B. 2003. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy. Cancer. 97, 3099–3106.

    Article  PubMed  CAS  Google Scholar 

  112. Aribi A., Kantarjian H., Koller C., Thomas D., Faderl S., Garcia-Manero G., Cortes J. 2008. The effect of interleukin-11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia. Cancer. 113, 1338–1343.

    Article  PubMed  CAS  Google Scholar 

  113. Montero A.J., Estrov Z., Freireich E.J., Khouri I.F., Koller C.A., Kurzrock R. 2006. Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome. Leuk. Lymphoma. 47, 2049–2054.

    Article  PubMed  CAS  Google Scholar 

  114. Hatae M., Ariyoshi Y., Fukuoka M., Furuse K., Noda K., Hirabayashi K., Yakushiji M., Ogawa M., Takaku F. 2005. An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma. Gan To Kagaku Ryoho. 32, 489–496.

    PubMed  Google Scholar 

  115. Hatae M., Noda K., Yamamoto K., Ozaki M., Hirabayashi K., Nishida T., Ohashi Y., Ogawa M., Takaku F. 2005. A clinical study of YM 294 (rhlL-11) in patients with gynecologic cancer. Gan To Kagaku Ryoho. 32, 479–487.

    PubMed  Google Scholar 

  116. Elson G.C., Lelievre E., Guillet C., Chevalier S., Plun-Favreau H., Froger J., Suard I., de Coignac A.B., Delneste Y., Bonnefoy J.Y., Gauchat J.F., Gascan H. 2000. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nature Neurosci. 3, 867–872.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia

    Ch. D. Hook & D. V. Kuprash

Authors
  1. Ch. D. Hook
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. V. Kuprash
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. V. Kuprash.

Additional information

Original Russian Text © Ch.D. Hook, D.V. Kuprash, 2011, published in Molekulyarnaya Biologiya, 2011, Vol. 45, No. 1, pp. 44–55.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hook, C.D., Kuprash, D.V. Interleukin-11, an IL-6-like cytokine. Mol Biol 45, 36–46 (2011). https://doi.org/10.1134/S0026893311010055

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893311010055

Keywords

Search

Navigation